In the first half of 2023, the public purchase of ICU equipment exceeded 30 billion yuan, with Mindray and Olympus ranking the top two

2023-09-01

The public purchase of ICU equipment exceeded 30-billion-yuan, year-on-year growth of 54.84%

According to MDCLOUD statistics, the public procurement amount of ICU equipment in the first half of 2023 was more than 30 billion, accounting for 29.48% of the total public procurement of medical devices in the industry, year-on-year growth of increase of 54.84%. ICU equipment involved a total of 6418 bidding units, an increase of 7.16%; A total of 14,520 winning units were involved, an increase of 16.33%; The number of brands involved was 1138, and the number of models was 4998, with a year-on-year growth rate of 8.38% and 18.35% respectively.

Figure 1 The proportion of ICU equipment purchase amount in the whole industry in the first half of 2023

Figure 2: Number of ICU equipment bidding/winning units in the first half of 2022 vs the first half of 2023 (units)

.02

The bidding amount of endoscope accounted for 38.83%

From the ranking of the winning amount of each product line, the first product line under ICU equipment in the first half of 2023 was endoscope, accounting for 38.83%; The second was ultrasonic imaging diagnostic equipment, accounting for 37.10%; In third place was ventilators, which accounted for 9.09%.

Figure 3. The proportion of bidding amount of each product line under ICU equipment in the first half of 2023

Mindray’s winning amount ranked first, accounting for 16.80% of the market sales

In the list of disclosed brand amounts, in the first half of 2023, Mindray ranked first, accounting for 16.80% of market sales, year-on-year increase of 29.15%. The main product lines include ultrasonic imaging diagnostic equipment, ventilators, and monitoring equipment. Followed by OLYMPUS (OLYMPUS), the market sales accounted for 11.67%, year-on-year increase of 30.37%, the main product line had endoscopes, cleaning and disinfection equipment; Ranked third was General Electric (GE Medical), the market sales accounted for 9.86%, an increase of 31.63%, the main product line had ultrasonic imaging diagnostic equipment, monitoring equipment.

Olympus Endoscope CV-290 ranked first in sales

By model, the top seller was OLYMPUS’s CV-290 endoscope; The second was the PHILIPS EPIQ 7C, an ultrasound imaging diagnostic device. In third place was GE Healthcare’s Voluson E10 ultrasound imaging device.

The amount of purchasing in Guangdong Province ranked first, and Hubei Province ranked second with a year-on-year increase of 135.11%

From the perspective of provincial procurement amount ranking, in the first half of 2023, the public procurement amount of ICU equipment ranked first in Guangdong Province, accounting for 12.77% of the purchase amount, ranking second and third were Hubei Province (5.78%) and Zhejiang Province (5.7%).

Table 3 Proportion of public purchase amount of ICU equipment by each province in the first half of 2023 (Top10)

The purchase amount of Fujian Cancer hospital was the highest

According to the bidding unit, the bidding unit with the highest amount of ICU equipment purchase in the first half of 2023 was Fujian Cancer Hospital, the second and third were Liaoning Provincial Medical Security Bureau and the First Affiliated Hospital of Bengbu Medical College, respectively.

Table 4 Ranking of public purchasing amount of ICU equipment by provinces in the first half of 2023 (Top10)

Fuzhou Tongchun Pharmaceutical Co., Ltd. had the highest bid amount

According to the winning units of ICU equipment in the first half of 2023, Fuzhou Tongchun Pharmaceutical Co., Ltd. ranked first, Covidien Medical Equipment International Trade (Shanghai) Co., Ltd. ranked second, and China National Pharmaceutical Group Shanxi Co., Ltd. ranked third.

Table 5 . Ranking of winning amount of ICU equipment tenderers in the first half of 2023 (Top10)

China is encouraging China end uses for more domestic products in latest years. Thus, more and more overseas manufacturers are planning localization in China. BradyKnows localization team has extensive experiences in facility establishment, audit, supplier evaluation, manufacturing, registration, and marketing in China. Pls feel free to let us know any questions on China entry via info@bradyknowsmedical.com

Data Source：MDCLOUD

Article Source：Joinchain

Translated & edited ： Bradyknows